CRATER tumor niches facilitate CD8+ T cell engagement and correspond with immunotherapy success

Aya Ludin1, Georgia L Stirtz2, Asaf Tal2

  • 1Harvard Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA 02138, USA; Stem Cell Program and Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA 02115, USA.

Cell
|October 18, 2025
PubMed

Insights

Researchers discovered Cancer Regions of Antigen Presentation and T cell Engagement and Retention (CRATERs) in melanoma. These regions are crucial for T cell activity and tumor killing, showing promise as biomarkers for immunotherapy success.

Area of Science:

  • Immunology
  • Oncology
  • Spatial Biology

Background:

  • T cell-mediated tumor killing is fundamental to immunotherapy efficacy.
  • Understanding the spatial organization of immune cells within tumors is critical for optimizing cancer treatments.

Purpose of the Study:

  • To identify specific microenvironmental domains that facilitate the immune response during cancer immunotherapy.
  • To investigate the role of these domains in T cell engagement and tumor killing in melanoma.

Main Methods:

  • Long-term in vivo imaging and high-resolution spatial transcriptomics in zebrafish melanoma models.
  • Multiplex imaging of human melanoma biopsies.
  • Analysis of T cell interactions and spatial distribution within tumor microenvironments.

Main Results:

  • Identification of Cancer Regions of Antigen Presentation and T cell Engagement and Retention (CRATERs) at stroma-melanocyte boundaries in both zebrafish and human melanoma.
  • CRATERs exhibit high density of CD8+ T cells and antigen-recognition molecules, facilitating prolonged T cell-melanoma cell interactions.
  • CRATER expansion and density correlate with activated T cell accumulation, tumor killing, and clinical response to immunotherapy (including immune checkpoint blockade).

Conclusions:

  • CRATERs represent key functional niches for T cell-mediated tumor killing during immunotherapy.
  • The density and characteristics of CRATERs may serve as a predictive biomarker for immunotherapy response in melanoma patients.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
952
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K